Literature DB >> 15489224

Cdk5/p35 phosphorylates mSds3 and regulates mSds3-mediated repression of transcription.

Zhen Li1, Gregory David, Kwok-Wang Hung, Ronald A DePinho, Amy K Y Fu, Nancy Y Ip.   

Abstract

Cyclin-dependent kinase 5 (Cdk5), a serine/threonine kinase that displays kinase activity predominantly in neurons, is activated by two non-cyclin activators, p35 or p39. Here, we report a physical and functional interaction between the Cdk5/p35 complex and mouse Sds3 (mSds3), an essential component of mSin3-histone deacetylase (HDAC) co-repressor complex. mSds3 binds to p35 both in vitro and in vivo, enabling active Cdk5 to phosphorylate mSds3 at serine 228. A mSds3 S228A mutant retained mSin3 binding activity, but its dimerization was not greatly enhanced by p35 when compared with wild type. Notably, p35 overexpression augmented mSds3-mediated transcriptional repression in vitro. Interestingly, mutational studies revealed that the ability of exogenous mSds3 to rescue cell growth and viability in mSds3 null cells correlates with its ability to be phosphorylated by Cdk5. The identification of mSds3 as a substrate of the Cdk5/p35 complex reveals a new regulatory mechanism in controlling the mSin3-HDAC transcriptional repressor activity and provides a new potential therapeutic means to inhibit specific HDAC activities in disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489224     DOI: 10.1074/jbc.M411002200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Authors:  Anja Büchner; Petranka Krumova; Sundar Ganesan; Mathias Bähr; Katrin Eckermann; Jochen H Weishaupt
Journal:  Neuromolecular Med       Date:  2014-11-13       Impact factor: 3.843

Review 2.  What signals are generated by anti-CD20 antibody therapy?

Authors:  Benjamin Bonavida
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

3.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

Review 4.  Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  FEBS Lett       Date:  2011-08-05       Impact factor: 4.124

5.  Cdk5 controls IL-2 gene expression via repression of the mSin3a-HDAC complex.

Authors:  Eric Lam; Tej K Pareek; John J Letterio
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Robert H Miller; Yan Yang
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

7.  Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors.

Authors:  Xiaozhong Shi; David C Seldin; Daniel J Garry
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

8.  p35 regulates the CRM1-dependent nucleocytoplasmic shuttling of nuclear hormone receptor coregulator-interacting factor 1 (NIF-1).

Authors:  Xiao-Su Zhao; Wing-Yu Fu; Winnie W Y Chien; Zhen Li; Amy K Y Fu; Nancy Y Ip
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 9.  Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsy.

Authors:  Aparna Banerjee Dixit; Jyotirmoy Banerjee; Manjari Tripathi; Chitra Sarkar; P Sarat Chandra
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

10.  Cdk5 Regulates Activity-Dependent Gene Expression and Dendrite Development.

Authors:  Zhuoyi Liang; Tao Ye; Xiaopu Zhou; Kwok-On Lai; Amy K Y Fu; Nancy Y Ip
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.